A recent analysis has uncovered a staggering disparity in clinical research: despite Indigenous populations facing the highest prevalence of Posttraumatic Stress Disorder (PTSD) and Substance Use Disorder (SUD), they have been systematically excluded from the scientific advancements of the last 25 years.
Key findings from the study include:
Erasure in Clinical Trials: Indigenous people represent only approximately 1% of participants in clinical research conducted over the last 2.5 decades, leaving a massive gap in data for these high-risk groups.
A Lack of Tailored Care: Although Indigenous communities have unique clinical and cultural needs, researchers identified only one study in the past several decades specifically designed to address those needs.
The Risk of Inaction: This persistent "pattern of neglect" threatens to cement existing health inequities. Without a radical shift toward inclusive and culturally specific research, Indigenous communities will continue to carry a disproportionate and unaddressed burden of trauma and addiction.
Ultimately, the study serves as a call to action: the clinical research community must move beyond generalized models and prioritize Indigenous-led interventions to break the cycle of heightened PTSD and SUD prevalence.
